Learn more

HANMI PHARM CO LTD

Overview
  • Total Patents
    194
  • GoodIP Patent Rank
    9,963
  • Filing trend
    ⇧ 21.0%
About

HANMI PHARM CO LTD has a total of 194 patent applications. It increased the IP activity by 21.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, Taiwan and Singapore. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are HASUMI KENICHIRO, JUVENTAS THERAPEUTICS INC and TILLOTTS PHARMA AG.

Patent filings in countries

World map showing HANMI PHARM CO LTDs patent filings in countries
# Country Total Patents
#1 Australia 94
#2 Taiwan 74
#3 Singapore 22
#4 Morocco 3
#5 Serbia 1

Patent filings per year

Chart showing HANMI PHARM CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kwon Se Chang 60
#2 Jung Sung Youb 58
#3 Woo Jong Soo 47
#4 Park Jae Hyun 42
#5 Kim Yong Il 38
#6 Choi In Young 37
#7 Lim Hyung Kyu 18
#8 Kim Dae Jin 18
#9 Suh Kwee Hyun 18
#10 Bae Sung Min 18

Latest patents

Publication Filing date Title
AU2019203034B1 Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
AU2018341729A1 Pharmaceutical composition including multi-unit spheroidal tablet containing esomeprazole and spheroidal pharmaceutically acceptable salt thereof, and method of preparing the pharmaceutical composition
AU2017244269A1 Composite capsule preparation containing tadalafil and tamsulosin and having improved stability and elution rate
TW201718629A A protein conjugate comprising multiple physiological polypeptides and an immunoglobulin Fc region
TW201710288A Novel insulin analogs
AU2015242657A1 Method for improving solubility of protein and peptide by using immunoglobulin Fc fragment linkage
TW201442723A A method of virus inactivation in composition comprising factor vii
TW201410704A A liquid formulation of long-acting insulin and insulinotropic peptide